← Leaderboards
Michael Benjamin Major
Univ Of North Carolina Chapel Hill
$9,815,030
Attributed
$13,115,463
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,115,463 · 11
By mechanism
R01$7,970,776 · 4
DP2$2,220,000 · 1
U54$1,755,147 · 2
P30$649,395 · 2
R21$520,145 · 2
Top collaborators
- Xiaoxin Chen9 shared
- Bernard E. Weissman7 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Elias Rosen$3,101,084
- Daniel E Michaud$205,141
- Bernard E. Weissman$16,032,468
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularSignal TransductionMalignant NeoplasmsPathway InteractionsProteomicsTranscription FactorMutationGenetic TranscriptionGenesSignal PathwayResponseTissuesPhenotypeGrowthStressProteinsInsightGene ExpressionCellsAffectCell LineMetabolismIn VitroGenetic
Grant awards (34)
METEOR-BioLogical Specimen Translation (METEOR-BLST)$844,906
U54 · FY2025 · CA · contact PI
Drugging NRF2 to improve radiation therapy in head and neck squamous cell carcinoma$647,754
R01 · FY2025 · CA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$618,054
R01 · FY2025 · CA
Mass Spectrometry$211,024
P30 · FY2025 · DK · contact PI
Identifying the effects of NRF2 signaling on lung squamous cell carcinoma development$158,365
R21 · FY2025 · CA
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$606,975
R01 · FY2024 · CA
METEOR-BioLogical Specimen Translation (METEOR-BLST)$386,855
U54 · FY2024 · CA · contact PI
Mass Spectrometry$216,070
P30 · FY2024 · DK · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$154,586
R01 · FY2024 · CA
METEOR-BioLogical Specimen Translation (METEOR-BLST)$422,630
U54 · FY2023 · CA · contact PI
Mass Spectrometry$222,301
P30 · FY2023 · DK · contact PI
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma$493,661
R01 · FY2022 · CA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$397,420
R01 · FY2022 · CA
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$169,196
R01 · FY2022 · CA
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$83,443
R01 · FY2022 · CA
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$81,195
R01 · FY2022 · CA
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$609,361
R01 · FY2021 · CA
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma$503,737
R01 · FY2021 · CA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$574,275
R01 · FY2020 · CA
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma$517,517
R01 · FY2020 · CA · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$46,650
U54 · FY2020 · CA · contact PI
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma$485,161
R01 · FY2019 · CA
Role of FOXP1 and WNT signaling in B-cell Lymphoma$298,274
R01 · FY2019 · CA · contact PI
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma$500,167
R01 · FY2018 · CA
Role of FOXP1 and WNT signaling in B-cell Lymphoma$307,500
R01 · FY2018 · CA · contact PI
Role of FOXP1 and WNT signaling in B-cell Lymphoma$307,500
R01 · FY2017 · CA · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$12,664
U54 · FY2017 · CA · contact PI
Role of FOXP1 and WNT signaling in B-cell Lymphoma$307,500
R01 · FY2016 · CA · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$20,893
U54 · FY2016 · CA · contact PI
Role of FOXP1 and WNT signaling in B-cell Lymphoma$307,500
R01 · FY2015 · CA · contact PI
Mass spectrometry-coupled hypermorphic functional genomics$164,360
R21 · FY2015 · CA · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$20,549
U54 · FY2015 · CA · contact PI
Mass spectrometry-coupled hypermorphic functional genomics$197,420
R21 · FY2014 · CA · contact PI
Exploitation of Near-Haploid Human Cells for Functional Gene Discovery$2,220,000
DP2 · FY2010 · OD · contact PI